Th17 cells promote osteoclastogenesis through IL-17-mediated induction of RANKL [177], and elevated Th17 cells or IL-17 may contribute to bone-related outcomes in LC [175]. This evidence concerns the gene IL17A and laryngotracheoesophageal cleft.